Search research articles
Contact Us
Filters
Showing results (131-140 of 141) with videos related to
Page
of 15
Sort By:
Journal of the National Cancer Institute
|
March 8, 2018
Genomic Amplifications and Distal 6q Loss: Novel Markers for Poor Survival in High-risk Neuroblastoma Patients
Pauline Depuydt, Valentina Boeva, Toby D Hocking, et al.
European Radiology Experimental
|
April 5, 2020
PRIMAGE project: predictive in silico multiscale analytics to support childhood cancer personalised evaluation empowered by imaging biomarkers
Luis Martí-Bonmatí, Ángel Alberich-Bayarri, Ruth Ladenstein, et al.
Journal of the National Cancer Institute
|
August 25, 2025
International neuroblastoma risk group consortium: a model of a networking for rare cancers
Susan L Cohn, Wendy B London, Gudrun Schleiermacher, et al.
JAMA Oncology
|
August 12, 2021
Recommendations for Age-Appropriate Testing, Timing, and Frequency of Audiologic Monitoring During Childhood Cancer Treatment: An International Society of Paediatric Oncology Supportive Care Consensus Report
Annelot J M Meijer, Marry M van den Heuvel-Eibrink, Beth Brooks, et al.
Oncotarget
|
August 31, 2016
MYCN and HDAC5 transcriptionally repress CD9 to trigger invasion and metastasis in neuroblastoma
Johannes Fabian, Desirée Opitz, Kristina Althoff, et al.
Science (New York, N.Y.)
|
December 8, 2018
A mechanistic classification of clinical phenotypes in neuroblastoma
Sandra Ackermann, Maria Cartolano, Barbara Hero, et al.
The Journal of Clinical Investigation
|
February 12, 2026
Mutated FGFR1 is an oncogenic driver and therapeutic target in high-risk neuroblastoma
Lisa Werr, Jana Boland, Josephine Petersen, et al.
Nature
|
October 16, 2015
Telomerase activation by genomic rearrangements in high-risk neuroblastoma
Martin Peifer, Falk Hertwig, Frederik Roels, et al.
JCO Precision Oncology
|
July 1, 2026
Frequency and Prognostic Significance of Genetic Abnormalities in a Subgroup of Patients With Intermediate-Risk Neuroblastoma: A SIOPEN Study
Hannah E Hartley, Fang Chyi Fong, Alem S Gabriel, et al.
American Journal of Medical Genetics. Part A
|
February 8, 2017
Childhood cancer predisposition syndromes-A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology
Tim Ripperger, Stefan S Bielack, Arndt Borkhardt, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 141) with videos related to
Sort By:
Page
of 15
Journal of the National Cancer Institute
|
March 8, 2018
Genomic Amplifications and Distal 6q Loss: Novel Markers for Poor Survival in High-risk Neuroblastoma Patients
Pauline Depuydt, Valentina Boeva, Toby D Hocking, et al.
European Radiology Experimental
|
April 5, 2020
PRIMAGE project: predictive in silico multiscale analytics to support childhood cancer personalised evaluation empowered by imaging biomarkers
Luis Martí-Bonmatí, Ángel Alberich-Bayarri, Ruth Ladenstein, et al.
Journal of the National Cancer Institute
|
August 25, 2025
International neuroblastoma risk group consortium: a model of a networking for rare cancers
Susan L Cohn, Wendy B London, Gudrun Schleiermacher, et al.
JAMA Oncology
|
August 12, 2021
Recommendations for Age-Appropriate Testing, Timing, and Frequency of Audiologic Monitoring During Childhood Cancer Treatment: An International Society of Paediatric Oncology Supportive Care Consensus Report
Annelot J M Meijer, Marry M van den Heuvel-Eibrink, Beth Brooks, et al.
Oncotarget
|
August 31, 2016
MYCN and HDAC5 transcriptionally repress CD9 to trigger invasion and metastasis in neuroblastoma
Johannes Fabian, Desirée Opitz, Kristina Althoff, et al.
Science (New York, N.Y.)
|
December 8, 2018
A mechanistic classification of clinical phenotypes in neuroblastoma
Sandra Ackermann, Maria Cartolano, Barbara Hero, et al.
The Journal of Clinical Investigation
|
February 12, 2026
Mutated FGFR1 is an oncogenic driver and therapeutic target in high-risk neuroblastoma
Lisa Werr, Jana Boland, Josephine Petersen, et al.
Nature
|
October 16, 2015
Telomerase activation by genomic rearrangements in high-risk neuroblastoma
Martin Peifer, Falk Hertwig, Frederik Roels, et al.
JCO Precision Oncology
|
July 1, 2026
Frequency and Prognostic Significance of Genetic Abnormalities in a Subgroup of Patients With Intermediate-Risk Neuroblastoma: A SIOPEN Study
Hannah E Hartley, Fang Chyi Fong, Alem S Gabriel, et al.
American Journal of Medical Genetics. Part A
|
February 8, 2017
Childhood cancer predisposition syndromes-A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology
Tim Ripperger, Stefan S Bielack, Arndt Borkhardt, et al.
Page
of 15